These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7598007)

  • 1. Anemia of malignancy.
    Bick RL
    Adv Exp Med Biol; 1995; 369():195-200. PubMed ID: 7598007
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythropoietin and anemia of cancer.
    Erslev AJ
    Eur J Haematol; 2000 Jun; 64(6):353-8. PubMed ID: 10901588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythropoietic stimulating factors and anemia in cancer patients: studies recommend prudence].
    Clopés Estela A; Mesía Nin R
    Farm Hosp; 2005 Mar; 29(2):73-4. PubMed ID: 16013928
    [No Abstract]   [Full Text] [Related]  

  • 4. Strategies to optimize the use of erythropoietin and iron therapy in oncology patients.
    Ford PA; Mastoris J
    Transfusion; 2004 Dec; 44(12 Suppl):15S-25S. PubMed ID: 15585001
    [No Abstract]   [Full Text] [Related]  

  • 5. Introduction. Improving the standard of care in the management of cancer-related anaemia: focus on darbepoetin alfa, a novel erythropoiesis-stimulating protein.
    Glaspy J
    Br J Cancer; 2001 Apr; 84 Suppl 1(Suppl 1):1-2. PubMed ID: 11308267
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of patients with anemia of malignancy with recombinant human erythropoietin.
    Herrmann F; Oster W; Mertelsmann R
    Contrib Nephrol; 1991; 88():238-45; discussion 246-7. PubMed ID: 2040185
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia.
    Bohlius J; Engert A; Schwarzer G
    JAMA; 2008 Dec; 300(24):2854-5; author reply 2855-7. PubMed ID: 19109112
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical application of recombinant erythropoietin in anemic cancer patients.
    Henry DH
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of recombinant human erythropoietin in oncology.
    Spivak JL
    Cancer Invest; 1990; 8(2):301-2. PubMed ID: 2400953
    [No Abstract]   [Full Text] [Related]  

  • 10. [Role of recombinant erythropoietin during the preoperative period].
    Janssens M; Lamy M
    Ann Fr Anesth Reanim; 1995; 14 Suppl 1():98-106. PubMed ID: 7486323
    [No Abstract]   [Full Text] [Related]  

  • 11. The Safety of Erythropoiesis-Stimulating Agents for the Treatment of Anemia Resulting from Chronic Kidney Disease.
    Robles NR
    Clin Drug Investig; 2016 Jun; 36(6):421-31. PubMed ID: 26894799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of mild anemia.
    Waltzman RJ
    J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-38-41. PubMed ID: 23570098
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anemia in miscellaneous diseases--mechanism and treatment--solid tumor].
    Shirakawa S; Minami N; Wada H; Katayama N
    Nihon Rinsho; 1991 Mar; 49(3):704-8. PubMed ID: 2041200
    [No Abstract]   [Full Text] [Related]  

  • 14. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
    Eschbach JW; Haley NR; Adamson JW
    Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for the use of recombinant human erythropoietin.
    Barosi G; Cazzola M; De Vincentiis A; Grossi A; Tura S
    Haematologica; 1994; 79(6):526-33. PubMed ID: 7896210
    [No Abstract]   [Full Text] [Related]  

  • 16. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia].
    Nikolaev AIu; Klepikov PV; Lashutin SV
    Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349
    [No Abstract]   [Full Text] [Related]  

  • 17. [The role of human recombinant erythropoietin in oncologic surgery].
    Mercuriali F
    Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Erythropoietin resistance].
    Branger B
    Nephrologie; 2002; 23(1):3-5. PubMed ID: 11887576
    [No Abstract]   [Full Text] [Related]  

  • 19. The application of recombinant erythropoietin in anemic patients with cancer.
    Spivak JL
    Semin Oncol; 1992 Jun; 19(3 Suppl 8):25-8. PubMed ID: 1615336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anemia in patients with cancer].
    Kobune M; Kato J; Niitsu Y
    Nihon Rinsho; 2008 Mar; 66(3):524-9. PubMed ID: 18330028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.